Mode
Text Size
Log in / Sign up
Phase 4 N=90 Randomized Double-blind Treatment

Effects of Intrauterine Flushing With Human Chorionic Gonadotropin on ICSI Outcome

Female Infertility

Enrolled (actual)
90
Serious AEs
0.0%
Results posted
Apr 2025
Primary outcome: Primary: Serum Level of TNF-alfa,IL-10, for All Participants in Three Study Group at Day of Ova Pickup Compared to That at Day of Embryo Transfer — 43.56; 41.59; 40.94; 30.33 pg/ml

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
hCG (Drug)
Age
Adult · 18+ yrs
Sex
Female
Sponsor
Omayma Ismail Khalaf
Primary completion
Jan 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Serum Level of TNF-alfa,IL-10, for All Participants in Three Study Group at Day of Ova Pickup Compared to That at Day of Embryo Transfer
43.56; 41.59; 40.94; 30.33; 38.06; 42.3
PRIMARY
Ultrasound Parameter (RI,PI)
0.49; 0.51; 0.5; 0.42; 0.48; 0.5
PRIMARY
Systole Flow/ Diastole Flow
2.05; 2.3; 2.01; 1.87; 2.21; 1.92
PRIMARY
TNF-alfa/IL-10 Ratio
1.89; 1.56; 1.71; 1.38; 1.66; 1.86
SECONDARY
Intra Cytoplasmic Sperm Injection Outcome
16; 12; 8; 14; 18; 22

Summary

a number of infertile women who were prepared for ICSI and immediately post ova pick up intrauterine flushing with human chorionic gonadotropin was done to study the effect of this drug on ICSI outcome and ultrasound parameter.

Eligibility Criteria

Inclusion Criteria

  • The patient's consent to participate in the research study is crucial for data collection and analysis.
  • Each pair of individuals undergoing IVF/ICSI procedures typically possess grade 1 (G1) embryos during the embryo transfer process.
  • The age range of the female participants varied from 18 to 40 years.
  • Infertility arising from female factors, including issues like blocked fallopian tubes, lack of ovulation, and unexplained fertility challenges, was examined.
  • Male-related factors contributing to infertility were also taken into consideration.
  • The procedure involved the transfer of grade one embryos during a fresh cycle.

Exclusion Criteria

Endometrioses, whether clinically suspected or discovered during laparoscopy, are of interest.

  • Instances of congenital abnormalities in the reproductive system are being examined.
  • Individuals above the age of forty are under consideration. 4. Individuals who do not possess G1 embryos are also included. 5. Patients with chronic systemic conditions (such as diabetes, hematologic disorders, hypertension, autoimmune disorders of the connective tissue, asthma, thyroid disorders) are a part of the study.
  • The presence of empty follicles is noted in stimulated cycles where no oocytes were obtained during the aspiration procedure.

-

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06684951). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search